Skip to main content
Top
Literature
1.
go back to reference Tombak A, Uçar MA, Akdeniz A, Yilmaz A, Kaleagası H, Sungur MA, Tiftik EN (2017) Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases. Indian J Hematol Blood Transfus 33:97–105CrossRefPubMed Tombak A, Uçar MA, Akdeniz A, Yilmaz A, Kaleagası H, Sungur MA, Tiftik EN (2017) Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases. Indian J Hematol Blood Transfus 33:97–105CrossRefPubMed
2.
go back to reference Rock G, Clark B, Sutton D, CAG, CAAN (2003) The Canadian apheresis registry. Transfus Apher Sci 29:167–177CrossRefPubMed Rock G, Clark B, Sutton D, CAG, CAAN (2003) The Canadian apheresis registry. Transfus Apher Sci 29:167–177CrossRefPubMed
3.
go back to reference Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH (2016) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for apheresis: the seventh special issue. J Clin Apher 31:149–162PubMed Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH (2016) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for apheresis: the seventh special issue. J Clin Apher 31:149–162PubMed
5.
go back to reference Howell C, Douglas K, Cho G, El-Ghariani K, Taylor P, Potok D, Rintala T, Watkins S (2015) Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British committee for standards in haematology. Transfus Med 25:57–78CrossRefPubMed Howell C, Douglas K, Cho G, El-Ghariani K, Taylor P, Potok D, Rintala T, Watkins S (2015) Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British committee for standards in haematology. Transfus Med 25:57–78CrossRefPubMed
6.
go back to reference Brecher ME, Owen HG (1996) Washout kinetics of colloidal starch as a partial or full replacement for plasma exchange. J Clin Apher 11:123–126CrossRefPubMed Brecher ME, Owen HG (1996) Washout kinetics of colloidal starch as a partial or full replacement for plasma exchange. J Clin Apher 11:123–126CrossRefPubMed
7.
go back to reference Auwerda JJ, Leebeek FW, Wilson JH, van Diggelen OP, Lam KH, Sonneveld P (2014) Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch. Transfusion 46:1705–1711CrossRef Auwerda JJ, Leebeek FW, Wilson JH, van Diggelen OP, Lam KH, Sonneveld P (2014) Acquired lysosomal storage caused by frequent plasmapheresis procedures with hydroxyethyl starch. Transfusion 46:1705–1711CrossRef
8.
go back to reference Wiedermann CJ, Joannidis M (2014) Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40:160–170CrossRefPubMed Wiedermann CJ, Joannidis M (2014) Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review. Intensive Care Med 40:160–170CrossRefPubMed
Metadata
Title
Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Insufficient Evidence to Support the Use of Hydroxyethyl Starch
Authors
Christian J. Wiedermann
Andrea Piccin
Giosue Gulli
Publication date
01-09-2017
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2017
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0833-9

Other articles of this Issue 3/2017

Indian Journal of Hematology and Blood Transfusion 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine